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Abstract 1 
Background 2 
Biomarkers of iron status are affected by inflammation.  In order to interpret them in individuals 3 
with inflammation the use of correction factors (CF) has been proposed. 4 
 5 
Objective 6 
The objective was to investigate the use of regression models as an alternative to the CF 7 
approach. 8 
 9 
Methods 10 
Morbidity data were collected during clinical examinations and morbidity recalls in a cross-11 
sectional study among 6-23 month old children with moderate acute malnutrition. C-reactive 12 
protein (CRP), α1-acid glycoprotein (AGP), ferritin (SF) and soluble transferrin receptor (sTfR) 13 
were measured in serum. Generalized additive, quadratic and linear models were used to model 14 
the relationship between SF and sTfR as outcomes and CRP and AGP either as categorical 15 
variables (model 1; equivalent to the CF approach), continuous variables (model 2) or CRP and 16 
AGP as continuous variables and morbidity covariates (model 3) as predictors. The predictive 17 
performance of the models was compared using ten-fold cross-validation and quantified using 18 
root mean squared errors (RMSE).  SF and sTfR were adjusted using regression coefficients 19 
from linear models.  20 
 21 
Results 22 
Cross-validation revealed no advantage of using generalized additive or quadratic models over 23 
linear models in terms of the RMSE. Linear model 3 performed better than models 2 and 1. 24 
Furthermore, we found no difference in CFs for adjusting SF and those from a previous meta-25 
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analysis.  Adjustment of SF and sTFR using the best performing model led to a 17% points 26 
increase and <1% point decrease in estimated prevalence of iron deficiency, respectively.   27 
 28 
Conclusion 29 
Regression analysis is an alternative to adjust SF and may be preferrable in research settings 30 
as it can take morbidity and severity of inflammation into account. In clinical settings the CF 31 
approach may be more practical.There is no benefit of adjusting sTfR. The trial was registered 32 
at the International Standard Randomised Controlled Trial Number Register 33 
(ISRCTN42569496). 34 
 35 
 36 
Keywords: Inflammation, α1-acid glycoprotein, correction factors, c-reactive protein, iron 37 
deficiency, regression analysis, serum ferritin, soluble transferrin receptor, young children. 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
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Background 49 
Anemia is a major public health issue and affects an estimated 71% of young children (< 5 50 
years) in west and central Africa (1). It can cause fatigue and has been associated with poor 51 
cognitive and motor development (2). Iron deficiency (ID) is believed to be responsible for 52 
50% of anaemia cases (3). Other causes of anemia include infectious diseases, 53 
hemoglobinopathies and deficiencies of folate, vitamin B12 or vitamin A  (2,4).   54 
 55 
Diagnosis of ID is necessary for a better understanding of the causes of anemia, identifying 56 
individuals who are most likely to benefit from iron supplements and evaluating effectiveness 57 
of interventions to combat anemia.  It is, however, a challenge because biomarkers of iron 58 
status, namely serum ferritin (SF) and serum soluble transferrin receptor (sTfR), are affected 59 
by inflammation (4,5). More specifically, SF acts as a positive acute phase reactant (6). sTfR 60 
is believed to be less affected by inflammation (4), although there are discrepancies in the 61 
literature regarding the relationship between inflammation, infection and sTfR. Some studies 62 
have shown that sTfR decreased in presence of inflammation (6,7) and malaria (8) while others 63 
found higher levels of sTfR in individuals with malaria (9,10) or observed positive 64 
relationships between inflammation markers and sTfR (10–14).  It is unclear what causes these 65 
discrepancies but they may be in part due to different levels of immunity, time course and 66 
severity of infection, as well as the infection causing the inflammation and anemia. 67 
In order to interpret biomarkers of iron status in the presence of inflammation, Thurnham et al 68 
(15,16) have suggested applying correction factors (CF) to measured concentrations of SF in 69 
individuals with inflammation defined as elevated serum levels of the acute phase proteins 70 
(APPs) serum c-reactive protein (CRP) and/or serum α1-acid glycoprotein (AGP). While SF 71 
has been adjusted for inflammation in several studies (10,14,15,17–21), there is still some 72 
debate as to whether it is useful to adjust sTfR concentrations (10,21–23).   73 
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 74 
The CF approach is easy to apply and has been used in a number of studies (10,14,17–20). 75 
However, it relies on single cut-offs and therefore ignores that the impact of inflammation on 76 
biomarkers of iron status depends on the severity of the inflammation (11,23) and may also 77 
depend on the cause of inflammation. In contrast, regression modelling, which has been 78 
proposed as an alternative to the CF approach (24), is not dependent on cut-offs and has the 79 
advantage that it can take morbidity covariates into account. It may therefore be a better option 80 
in populations with a high prevalence of infections. One concern about the use of linear 81 
regression models is that the relationships between APPs, namely CRP and AGP, and 82 
biomarkers of iron status are not linear (24) and it may thus be necessary to use more flexible 83 
regression models. Regression models have previously been used to adjust for inflammation 84 
(22,23) but more studies are needed, in particular in contexts where infections as well as 85 
malnutrition are common.  86 
 87 
The objective of this study was to investigate the use of regression models in adjusting 88 
biomarkers of iron status for the effect of inflammation in young children with moderate acute 89 
malnutrition in Burkina Faso where, as previously shown, inflammation and morbidity are 90 
common (25).  91 
 92 
Materials and methods 93 
Study area and population 94 
The data for this paper were baseline data collected as part of the TreatFOOD trial, a 95 
randomized trial with the objective to assess effectiveness of 12 supplementary foods for 96 
treatment of moderate acute malnutrition, defined as a weight-for-height between –3 and –2 z-97 
scores and/or a mid-upper arm circumference (MUAC) between 115 and 125 mm. As 98 
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previously described (26), the trial was carried out in 5 health centers in the Province du 99 
Passoré, Burkina Faso. The study catchment area covered a total of 143 villages and a total 100 
population of ~ 258,000. 101 
 102 
Children aged 6–23 months with moderate acute malnutrition, resident in the catchment area, 103 
and whose parents/guardians provided consent for their children to participate were included. 104 
Children who were hospitalised or treated for severe acute malnutrition in the previous two 105 
months, children with a haemoglobin<5 g/dL, children who were already enrolled in a 106 
nutritional programme, and those who had medical complications requiring hospitalisation 107 
were not included. Screening for participants was carried out by community health workers 108 
using MUAC tapes and designated screening teams using both MUAC and weight-for-height 109 
z-score (WHZ). In addition, children could be referred from a health centre or could present at 110 
site on carer´s initiative. Recruitment took place from September 2013 until August 2014.  111 
 112 
Data collection 113 
Socio-demographic data were collected by trained interviewers. Body weight was measured 114 
to the nearest 0.1 kg using an electronic scale with double weighing function (Seca model 115 
881 1021659). Length was measured to the nearest 0.1 cm using a standard UNICEF wooden 116 
measuring board.  All children were measured lying down.  MUAC was measured on the left 117 
arm to the nearest 1 mm. During clinical examinations and 14-day retrospective morbidity 118 
interviews research nurses collected the following morbidity data: rash, skin infection, runny 119 
nose, cough, ear discharge, upper respiratory infection, lower respiratory infection, diarrhea, 120 
fever and malaria as well as history of fever, cough, diarrhea, vomiting, rash and swelling. 121 
Venous blood (2.5 ml) was collected from the arm. One drop was used for diagnosis of 122 
malaria using a rapid diagnostic test that detects histidine rich protein 2  synthesized by the 123 
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Plasmodium falciparum malaria parasite (Bioline, Malaria Ag P.f, Standard diagnostics Inc.) 124 
and one drop of blood was used to estimate haemoglobin concentration using a HemoCue 125 
device (HB 301, Ängelholm, Sweden). The HemoCue was calibrated at the end of every 126 
month with a control solution. The remaining blood was added to a sample tube with clot 127 
activator (BD reference #368492) and transported to the trial lab in a cold box at 2-8°C.  128 
Serum was isolated following centrifugation at 700 x g for 5 minutes (EBA 20 S Hettich) and 129 
stored at -20⁰C until shipment to VitMin Lab in Willstaedt, Germany for analysis of CRP, 130 
AGP, SF and sTfR using a combined sandwich enzyme-linked immunosorbent assay (27).  131 
All samples were measured in duplicate and both intra- and interassay coefficient of variation 132 
were <10%. Samples were frozen and thawed only once prior to analysis. 133 
 134 
The thresholds used for defining abnormal values were as follows: Hemoglobin <11 g/L (28), 135 
SF <12 µg/L (28),  sTfR >8.3 mg/L (27), CRP >5 mg/L (24), AGP >1 g/L (24). Fever was 136 
defined as an axillary temperature > 37.5 °C. Upper and lower respiratory tract infections were 137 
diagnosed by experienced paediatric nurses based on an adapted version of the Integrated 138 
Management of Childhood Illnesses  guidelines  (29,30). Diarrhoea was defined as three or 139 
more loose watery stools per day.  140 
 141 
Data handling and statistical analysis 142 
Data were double entered into Epidata 3.1. software (Epidata Association, Odense, Denmark) 143 
and double entry checks were carried out on a daily basis. All statistical analyses were carried 144 
out using  the statistical software R (31). P-values <0.05 were considered to be significant. 145 
Characteristics of the study population were summarized as percentage, mean ± SD or, if not 146 
normally distributed, as median (interquartile range). Scatter plots with a best-fitting local 147 
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regression curve were used to display the possibly nonlinear relationships between biomarkers 148 
of iron status and acute phase proteins.  149 
 150 
Three types of models were used to predict logarithm-transformed SF and sTfR, namely 151 
generalized additive models (GAM), which flexibly allow modelling of nonlinear 152 
relationships, quadratic models, and linear models. For each of these three model types, five 153 
models per iron status biomarker as outcome and with either i) CRP as continuous variable, ii) 154 
AGP as continuous variable, iii) CRP and AGP as continuous variables,  iv) both acute phase 155 
proteins and morbidity covariates, or v) inflammation groups as independent variables were 156 
built. The inflammation groups used were: no inflammation, incubation (CRP >5mg/L only), 157 
early convalescence (CRP >5mg/L and AGP >1g/L) and late convalescence (AGP >1 g/L only) 158 
as previously described by Thurnham et al (15). Stepwise backwards elimination was used for 159 
variable selection. The first four models were fitted to the subset of the data consisting of 160 
individuals who had a CRP >5mg/L and/or AGP >1g/L and the last model was built in the full 161 
dataset, since the base category were children without inflammation. Model checking was 162 
based on residual and normal probability plots. 163 
 164 
The predictive performance of the models was compared using ten-fold cross-validation.  More 165 
specifically, the data set was randomly split into ten subsets of equal size. In turn each of these 166 
one-tenth of the data set (test set) was left out and models fitted to the remainder part of the 167 
data (training set). For both SF and sTfR predictive performance was evaluated using root mean 168 
squared errors (RMSEs) between observed and predicted values, where a lower RMSE 169 
indicates better performance. 170 
 171 
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Following the cross-validation, adjusted SF and sTfR concentrations were calculated using 172 
regression coefficients from the models. As an example, the formula for calculation of adjusted 173 
SF concentrations using the model with both CRP and AGP as independent variables would 174 
be: Adjusted SF= exp(log SF - βCRP*CRP- βAGP *AGP), where βCRP is the regression coefficient 175 
from the model and logSF is logarithm transformed SF. 176 
 177 
Only concentrations in individuals with CRP >5 mg/L and/or AGP >1 g/L were adjusted. Since 178 
back-transformed regression coefficients from logarithm-transformed model are equal to the 179 
ratio of geometric means, the model with inflammation groups as independent variable 180 
corresponds to the correction factor approach previously described by Thurnham et al (15,16) 181 
where ratios of geometric means are converted to correction multipliers by dividing 1 by the 182 
ratio.  We compared our results to the ratios calculated in a recent meta-analysis (15) for both 183 
infants (<12 month) and children (up to 18 years) using approximate t-tests. Prevalence of iron 184 
deficiency was calculated for unadjusted and adjusted values as well as separately for 185 
individuals with and without inflammation based on the cut-offs for SF and sTfR mentioned 186 
above.  187 
 188 
Ethical considerations 189 
The study was approved by the Ethics Committee for Health Research of the government of 190 
Burkina Faso (2012-8-059) and consultative approval was obtained from the Danish National 191 
Committee on Biomedical Research Ethics (1208204). The study was carried out in 192 
accordance with the declaration of Helsinki. All children recruited in need of medical 193 
treatment received treatment free of charge according to an adapted version of the Integrated 194 
Management of Childhood Illnesses guidelines (29,30) and national protocol. Consent was 195 
obtained from carers, prior to inclusion, verbally and in writing (signature or fingerprints). 196 
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Data were kept confidential and in a locked facility. The trial was registered in the 197 
International Standard Randomised Controlled Trial Number registry under the number 198 
ISRCTN42569496.  199 
 200 
Results  201 
Sample population characteristics 202 
As previously reported 1609 children were enrolled in the TreatFOOD study  (25). Among 203 
these, 1564 children (82.1%) had baseline SF and sTfR data and were included in the analysis 204 
presented here. Background characteristics are presented in Table 1 and have been described 205 
in more detail elsewhere (25). As previously reported, infections and inflammation were 206 
common (25). More than two thirds of children had a symptom or infection diagnosed during 207 
the physical examination, 35.8% (n=561) had elevated CRP and 66.4% (n=1039) had elevated 208 
AGP (Table 1). Only 11.1% (n=174) of children did not have any inflammation, history of 209 
illness or infections. Anaemia was also common (Table 1). 210 
 211 
Model selection: Serum ferritin 212 
Although the relationship between SF and APPs was not completely linear as shown in Figure 213 
1 A,B and also confirmed by the generalized additive model (p-value of smooth terms <0.05), 214 
SF appears to steadily increase for APP values above the cut-off indicating inflammation and 215 
levels off at high concentrations of the acute phase proteins (Figure 1 A,B). In line with the 216 
latter observation, cross-validation revealed no advantage of using more complex GAM and 217 
quadratic models over linear models in terms of the RMSEs, which were 0.953, 0.952 and 218 
0.957 for the GAM, quadratic and linear models with APPs in continuous form as predictors.  219 
Since there appears to be no gain from using more complex models the remainder of the 220 
analysis is based on linear models. While model type did not greatly affect the predictive 221 
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performance of the models, the choice of covariates had more of an impact.   The RMSEs were 222 
reduced if both APPs were included as continuous rather than a categorical variables and they 223 
were further reduced if morbidity data were included in addition to APPs (Table 2). APPs, 224 
malaria, lower respiratory tract infection as well as history of fever were significantly 225 
associated with increased log SF levels (Table 2). RMSEs for models not presented in Table 226 
2 can be found in Supplemental Table 1.  227 
 228 
Model selection: Serum soluble transferrin receptor 229 
Similarly to SF the relationship between sTfR and APPs was not completely linear as 230 
demonstrated by Figure 1 C, D and confirmed by the generalized additive model (p-value of 231 
smooth terms <0.05).  Soluble transferrin receptor concentrations appeared to steadily decrease 232 
as CRP increases for CRP concentrations >5mg/L. There appeared to be an inverted U-shaped 233 
relationship between sTfR and AGP with the apex around an AGP concentration of 234 
approximately 1.5g/L (Figure 1 D). In line with the observation that sTfR concentration 235 
appeared to decrease in individuals with inflammation, cross-validation revealed no advantage 236 
of using more complex GAM and quadratic models over linear models in terms of the RMSEs, 237 
which were 0.426, 0.427 and 0.429 for the GAM, quadratic and linear models including APPs 238 
in continuous form as predictors. The remainder of the analysis was therefore based on the 239 
linear models. RMSEs for models not presented in Table 2 can be found in Supplemental 240 
Table 1. Similarly to the SF models, the sTfR models performed better if APPs were included 241 
in continuous as opposed to categorical form and performance was further improved if 242 
morbidity covariates were added (Table 2). If both CRP and AGP were included in the models, 243 
only CRP remained significant. CRP was associated with a decrease in sTfR, while malaria, 244 
fever and acute diarrhea were associated with higher concentrations of sTfR (Table 2). 245 
 246 
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Comparison of study generated to meta-analysis CFs for adjusting SF 247 
The ratio of geometric means between reference and the inflammation groups did not differ 248 
from the ones calculated in children in the meta-analysis of Thurnham et al (15). The ratio for 249 
the early convalescence vs reference group generated based on our data was different from the 250 
one calculated by Thurnham et al. (15)  for the subgroup of infants (<12 months) but did not 251 
differ for the other two groups (Table 4). However, if comparison was made only based on 252 
infants under 12 months old in our data as well, this difference disappeared (data not shown). 253 
 254 
Impact of adjustment on estimated prevalence of ID 255 
 Adjusting SF concentrations for the impact of inflammation and infection led to a lower mean 256 
SF and a higher estimated prevalence of ID in the sample by 12, 14 and 17 percentage points 257 
for model 1 (linear model with inflammation categories as predictor), model 2 (linear model 258 
with APPs as continuous variables) and model 3 (linear model with APPs as continuous 259 
variables and morbidity covariates), respectively (Table 3). Impact of adjustment of SF is also 260 
shown in Figure 2 A, B.  The estimated prevalence based on adjustment using models 2 or 3 261 
were very close to the prevalence of ID in the subset of children without inflammation and 262 
without inflammation and/or infection, respectively (Table 3). Estimated prevalence calculated 263 
using model 1, which corresponds to the CF approach, was slightly lower than based on the 264 
other 2 models. Adjusting sTfR concentrations reduced the prevalence of ID by 7 percentage 265 
points based on model 1 and increased the prevalence of ID by 3 and < 1 percentage points if 266 
based on model 2 and model 3, respectively (Table 3). As also demonstrated in Figure 2 C, 267 
D, the impact of adjustment on sTfR was therefore small. 268 
 269 
Discussion 270 
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Our results confirm that the relationship between the two APPs, CRP and AGP, and biomarkers 271 
of iron status is not completely linear. Nevertheless, linear models perform well and there was 272 
no advantage in using the more complex quadratic or GAM models to predict SF and sTfR 273 
concentrations.  274 
 275 
To adjust SF for inflammation, the use of regression models is an alternative and may be 276 
preferable to the CF approach for several reasons.  First, the relationship between the APPs and 277 
SF is fairly linear for concentrations above thresholds used to indicate inflammation, and in 278 
terms of predictive performance, there does not appear to be any advantage of using more 279 
flexible models.  Second, we observed higher SF with increasing severity of inflammation and 280 
as a result models performed better if CRP and AGP were treated as continuous rather than 281 
categorical variables.  Third, while the difference in RMSE between model 2 and 3 and 282 
resulting prevalence of ID was small, the results indicate that including morbidity leads to a 283 
more precise estimate and including morbidity is not possible in the CF approach.  Lastly, the 284 
estimated adjusted prevalence of ID based on the linear models 2 and 3 was similar to the 285 
prevalence of ID in the subset of children without inflammation or without inflammation and 286 
infection, respectively. Overall, as expected, adjustment of SF using the 3 models led to an 287 
increase in estimated prevalence of ID, which is consistent with findings of previous studies 288 
(10,18,20,22).  289 
 A disadvantage of regression analysis is that it is more complex than the CF approach and 290 
requires available population data. It is unclear exactly how large a sample would be required 291 
to allow prediction models to be obtained from regression techniques but we estimate that for 292 
sample sizes below 50 the data would not be sufficiently informative. 293 
While we believe that regression analysis using both APP and morbidity data would give a 294 
more reliable estimate of iron status and is preferable at population level for example when 295 
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evaluating effectiveness of interventions, it is not practical in a clinical setting for identification 296 
of ID in an individual unless the regression coefficients and devices are available to carry out 297 
the calculations. In this case the use of a CF would be better. Interestingly, even though 298 
morbidity appears to play an important role, we found no differences in CFs calculated in 299 
apparently healthy children as part of a meta-analysis (15) compared to the ones we calculated 300 
as part of our study. In clinical settings where regression approach would be impractical and 301 
where population data are not available, the use of meta-analysis correction factors may 302 
therefore be appropriate to adjust SF even in children with moderate acute malnutrition.   303 
 304 
In the case of sTfR, the models also performed better if both APPs and morbidity covariates 305 
were included. However, while in the case of SF it makes sense to pick the best performing 306 
model for adjustment, this may not be the case for sTfR. As previously mentioned there is still 307 
some debate as to whether sTFR should be adjusted for inflammation (10,21–23) and there are 308 
discrepancies in the literature regarding the relationship between sTFR and inflammation or 309 
infection.  We found a negative relationship between CRP and sTfR, as others have previously 310 
reported (6,7).  Therefore, since lower sTfR is associated with better iron status, this would 311 
suggest better iron status in individuals with elevated CRP.  sTfR is a marker of erythropoiesis 312 
as well as tissue iron deficiency (5) and lower levels of sTfR in children with inflammation 313 
may be a result of suppression of erythropoiesis, which occurs possibly through the actions of 314 
inflammatory cytokines (32). In contrast, we and others (9,10,33,34) found higher levels of 315 
sTfR in individuals with malaria.  It is possible that erythropoiesis is depressed during and 316 
increases shortly after the acute malaria infection stage. In line with this it has been shown that 317 
while erythropoietin is increased in malaria (35,36), the bone marrow response to 318 
erythropoietin may be suppressed until parasites have been cleared (36). We measured malaria 319 
using an rapid diagnostic test, which can stay positive for over a month following treatment 320 
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(37,38)  so it is not possible to know whether a positive test reflects current or recent malaria. 321 
However, as previously mentioned in contrast to our results others have observed positive 322 
relationships between inflammation markers and sTfR (10–14) or shown that that sTfR 323 
decreased in malaria (8).  In addition to increased erythropoiesis, higher sTFR concentrations 324 
in children with infections may also be due to poorer iron status. Adjusting for morbidity may 325 
therefore lead to over-adjustment. Adjustment for CRP may however be justified since elevated 326 
levels of CRP in our study were associated with lower levels of sTfR and inflammation may 327 
therefore lead to underestimation of ID, but the impact in our study was small.  Overall, 328 
considering the inconsistencies in the literature regarding association between sTfR and 329 
inflammation, the possible risk for over adjustment (if adjusting for morbidity as well as CRP), 330 
and that the impact of adjustment was overall small, we believe there is no benefit in adjusting 331 
sTfR, which is in agreement with findings from other studies (21,22). 332 
 333 
We found a large difference in estimated prevalence of ID based on sTfR and SF, even after 334 
adjustment, which is consistent with findings of other studies (10,14,22,39,40).  Since SF and 335 
sTfR measure different aspects of iron status, differences in prevalence may not be surprising. 336 
However, the large difference in prevalences may also have other causes. First, it may be 337 
related to the cut-offs used. There are no internationally agreed cut-offs for sTfR (4) and the 338 
appropriateness of the 12 µg/L cut-off for SF has also been questioned  (41). However, although 339 
both lower (41) and higher (42) cut-offs for SF in under 12 months old infants have been 340 
suggested, the ESPGHAN committee on nutrition concluded in a position paper that the 12 341 
µg/L cut-off leads to over- rather than underestimation of ID (43), which would not explain the 342 
differences we found. Secondly, it has also been suggested that SF and sTfR may not be useful 343 
for diagnosis of ID until 9 months of age  ID  (41) but excluding children under 9 months did 344 
not really impact prevalence of ID based on sTfR as well as adjusted or unadjusted SF (data 345 
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not shown).  Furthermore, while we adjusted SF for inflammation we did not account for the 346 
fact that children with inflammation and/or infection may also be more iron deficient than 347 
children without and the estimated prevalence of ID after adjustment may be underestimated. 348 
Lastly, SF may also be affected by other factors such as liver disease (44) and there may be 349 
other unknown causes of elevated sTfR in this population, such as thalassemia (45), sickle cell 350 
anemia (5); a limitation of our study is that we did not collect data on hemoglobinopathies.  A 351 
further limitation is that we were not able to compare adjustments to a gold standard for ID, 352 
namely bone marrow iron and it is therefore difficult to say which biomarker with which 353 
adjustment iron best reflects iron status in this population.   354 
 355 
In conclusion, regression analysis is an alternative and may be preferable to the CF approach 356 
when adjusting SF for inflammation since it allows accounting for severity of inflammation 357 
and morbidity and we recommend investigating whether this approach would prove to be useful 358 
in other populations as well. However, in clinical settings where the regression approach would 359 
be impractical the use of meta-analysis CFs may be appropriate. We furthermore believe that 360 
there is no benefit of adjusting sTfR. Moreover, considering the large difference in estimated 361 
prevalence of ID based on SF and sTfR more research is needed as to which biomarker, using 362 
which cut-offs for the markers, and with which adjustment can best define iron status of 363 
children from low income areas with high infectious disease burden.  364 
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Tables and Figures 
Table 1. Characteristics of 1564 6-23 month old children with moderate acute 
malnutrition in Burkina Faso1 
 
Sex, male    45.1 (706) 
Age, months  11.4 [8.2-16.2] 
 
Anthropometry  
    Inclusion category  
            Low MUAC only2 29.0 (454) 
            Low WHZ3 and low MUAC 50.1 (784) 
            Low WHZ only 21.0 (326) 
   Height-for-age  z-score <-2 
 
37.7 (590) 
Morbidity  
   Illness according to maternal recall4 37.5 (587) 
   Illness according to physical examination 71.6 (1121) 
   Malaria4 
 
40.2 (626) 
Laboratory tests   
Serum CRP, mg/L (IQR) 2.3 [0.8-9.4] 
      0-5 mg/L 64.1 (1002) 
            >5- 10mg/L 11.7 (183) 
      >10-20mg/L 9.2 (144) 
            >20-40 mg/L 7.0 (110) 
      >40 mg/L 
 
8.0 (125) 
Serum AGP, g/L 1.2  [1.19-1.24] 
    0-1 g/L 33.0 (517) 
    >1-2 g/L 52.4 (819) 
    >2-3 g/L 10.8 (169) 
    >3 g/L 3.8 (59) 
      
      Hemoglobin,  g/L 
   < 11 g/L 
 
 
10.0 ± 1.6 
70 (1095) 
1 Values are % (n) for categorical variables, mean ± SD for continuous variables with a normal 
distribution, or median [IQR] for continuous variables with a skewed distribution. IQR, 
interquartile range; MUAC, mid upper arm circumference; WHZ, weight-for-height z-score; 
CRP, C-reactive protein; AGP, α1-acid glycoprotein. 
2MUAC > 115mm and <125mm 
3 WHZ > -3 &  < -2 z-scores 
4 Data missing: Ill according to maternal recall (9), malaria (6) 
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Table 2. Prediction models for log-transformed serum ferritin and soluble transferrin receptor in 1564 young children from Burkina Faso1 
     
 Log serum ferritin (µg/L)2  Log serum soluble transferrin 
receptor (mg/L)3 
 
 Coefficient (95% CI) p-value RMSE Coefficient (95% CI) p-value RMSE 
Model 1. Inflammation Categories3         
   CRP >5mg/L 0.253 (-0.11, 0.625) 0.2  0.142 (-0.014, 0.299) 0.07  
   CRP >5mg/L and AGP >1g/L 1.094 (0.969, 1.220) <0.001  0.149 (0.096, 0.202) <0.001  
   AGP >1g/L 0.432 (0.305, 0.559) <0.001 1.027 0.147 (0.094, 0.201) <0.001 0.432 
 
Model 2. Acute phase proteins in continuous form 
      
   CRP 0.015 (0.012, 0.018) <0.001  -0.003 (-0.004,  -0.002) <0.001  
   AGP 0.454 (0.338, 0.571) <0.001 0.957 -  0.429 
 
Model 3. Acute phase proteins in continuous form 
and morbidity 
      
   CRP 0.014 (0.010, 0.017) <0.001  -0.004 (-0.006, -0.003) <0.001  
   AGP 0.348 (0.232, 0.463) <0.001  -   
   Malaria 0.426 (0.310, 0.541) <0.001  0.259 (0.209, 0.309) <0.001  
   Lower respiratory tract infection 0.139 (0.008, 0.269) 0.04  -   
   History of fever 0.316 (0.177, 0.455) <0.001  -   
   Fever -   0.072 (0.009, 0.136) 0.03  
   Acute diarrhoea 
 
-  0.927 0.132 (0.029, 0.234) 0.01 0.410 
1 CRP, C-reactive protein; AGP, α1-acid glycoprotein; RMSE, root mean squared error from 10-fold cross-validation. 
2 Model 1: Adjusted R2 =0.159 ; Model 2: Adjusted R2 = 0.238; Model 3: Adjusted R2 =0.293 
3 Model 1: Adjusted R2 =0.023; Model 2: Adjusted R2 =0.023; Model 3: Adjusted R2 = 0.113. 
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Table 3.  Estimated prevalence of iron deficiency (ID) with and without adjustment in 1564 6-23 month old children with moderate acute 
malnutrition1                                                                                                                                                         
  Serum ferritin  
(µg/L) 
 Serum soluble transferrin receptor  
(mg/L) 
     
 n Median (IQR) ID5 %, (n) Median (IQR) ID5 %, (n) 
Without adjustment      
   All participants 1564 33.4 (13.5-74.0) 21.0 (329) 12.6 (9.1-17.3) 82.9 (1296) 
   Participants with inflammation  
       (CRP>5 and/or AGP >1) 
1070 44.4 (18.9-91.6) 14.7 (157) 13.3 (9.7-18.2) 85.7 (917) 
   Participants without inflammation 494 18.9 (9.5-40.4) 34.8 (172) 11.2 (8.4-15.3) 76.7 (379) 
   Participants without inflammation and/or  illness   174 15.4 (9.3-29.2) 38.6 (66) 8.14 (8.05-8.23) 72.4 (126) 
      
With adjustment      
   Model 1. Linear model with     
      inflammation categories 2, 3  
1564 19.6 (9.2-31.3) 32.9 (516) 11.4 (8.3-15.6) 
 
75.6 (1182) 
 
   Model 2. Linear model with CRP and AGP     
      as continuous variables3,4 
1564 
 
17.5 (8.7-33.5) 
 
35.4 (553) 
 
13.1 (9.6- 18.1) 
 
86.1 (1347) 
 
   Model 3. Linear models with CRP, AGP and  
             morbidity 3,5 
1564 
 
    16.0 (8.0-30.0) 38.3 (587) 12.4 (9.2-16.9) 
 
83.6 (1305) 
 
 
1 ID, iron deficiency; IQR, interquartile range; CRP, C-reactive protein; AGP,  α1-acid  glycoprotein. 
2 Inflammation categories were: i.no inflammation, ii.CRP >5mg/L, iii. CRP >5mg/L and AGP >1g/L and iv. AGP >1mg/L. Model 1 is equivalent to the CF approach  
   described by Thurnham et al (15). 
3 Only biomarker concentrations in individuals with inflammation (CRP>5mg/L and AGP>1g/L) were adjusted (n=1070) but median and % ID refer to the full sample. 
4 In the sTfR model only CRP was significant. 
5  Morbidity variables included in the serum ferritin model were malaria, lower respiratory tract infection and history of fever and in the sTfR model malaria, fever and   
   acute diarrhea. 
5 Cut-offs used to define ID were serum ferritin<12 µg/L and serum soluble transferrin receptor >8.3 mg/L. 
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Table 4. Comparison of study-generated and meta-analysis geometric mean ferritin ratios for inflammation groups 
versus no inflammation group1 
 
 Ratio (95% CI) 
 Study generated 
 
Metaanalysis2    
 (n=1564) Infants (n=1278) p-value3 
 
Children (n=3695) p-value3 
CRP>5mg/L vs no 
inflammation 
1.29 (0.89-1.87) 1.13 (0.9, 1.41) 0.54 1.56 (1.22-1.99) 0.36 
CRP>5mg/L and 
AGP>1mg/L vs no 
inflammation 
2.99 (2.63-3.39) 2.09 (1.66-2.63) 0.006 2.55 (1.37-4.72) 0.61 
AGP>1mg/L vs no 
inflammation 
 
1.54 (1.36-1.75) 1.42 (1.14-1.76) 
 
0.52 1.53 (1.15-2.04) 0.97 
1 CI, confidence interval; CRP, c-reactive protein; AGP, α1-acid glycoprotein. 
2 Geometric mean ferritin ratios for infants (aged <12 months) and children (aged up to 18 years) from a meta-analysis carried 
out by Thurnham et al (15); 3 p values based on approximate t-tests 
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Figure 1. Relationship between acute phase proteins and biomarkers of iron status in 1564 6-
23 month old children.  
(A) Relationship between C-reactive protein (CRP) and serum ferritin (SF); (B) Relationship 
between CRP and soluble transferrin receptor (sTfR); (C) Relationship between α1-acid 
glycoprotein (AGP) and SF; (D) Relationship between AGP and sTfR. Grey dots represent 
serum concentrations of iron status biomarkers (SF or sTfR). Solid black line is the best fitting 
local regression curve with 95% confidence interval (CI). Dotted line indicates the cut-off used 
to define inflammation, i.e. 5mg/L for CRP and 1 g/L for AGP. 
 
 
Figure 2. Impact of adjusting biomarker concentrations on relationship with acute phase 
proteins in 1564 6-23 month old children in Burkina Faso.    
(A) Impact of adjusting serum ferritin (SF) on relationship with C-reactive protein (CRP); (B) 
Impact of adjusting soluble transferrin receptor (STfR)  on relationship with CRP; (C) Impact 
of adjusting serum ferritin (SF) on relationship with α1-acid glycoprotein (AGP); (D) Impact 
of adjusting sTfR on relationship with AGP. Grey dots indicate unadjusted SF or sTFR 
concentrations and black dots indicate values adjusted for inflammation. Adjusted SF and sTfR 
concentrations were calculated using regression coefficients for CRP, AGP and morbidity 
covariates from linear models predicting log-transformed SF and sTfR concentrations. 
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Supplemental Table 1. Root mean squared error (RMSE) for predictive models for log-transformed serum 
ferritin (µg/L) and soluble transferrin receptor (mg/L) from 10-fold cross validation in 1564 6-23 months 
old children with moderate acute malnutrition. 
 
  
Serum ferritin 
(µg/L) 
 
 
Serum soluble transferrin 
receptor (mg/L) 
1.Generalized additive models   
1.1. CRP only 0.978 0.428 
1.2. AGP only 0.992 0.43 
1.3. CRP and AGP  0.953 0.426 
1.4. CRP, AGP and morbidity covariates 0.925 0.408 
 
2. Quadratic models 
  
2.1. CRP only 0.976 0.429 
2.2. AGP only 0.992 0.430 
2.3. CRP and AGP  0.952 0.427 
2.4. CRP, AGP and morbidity covariates 0.924 0.409 
 
3. Linear models 
  
3.1. Inflammation Categories 1.027 0.432 
3.2. CRP  0.982 0.429 
3.3. AGP  0.992 0.433 
3.4. CRP and AGP  0.957 0.429 
3.5. CRP, AGP and morbidity 0.927 0.410 
